Christopher A. Hatwig Wins Prestigious Award for Work to Empower Pharmacy Profession

Christopher A. Hatwig Wins Prestigious Award for Work to Empower Pharmacy Profession

Hatwig to be Awarded at American Society of Health-System Pharmacists Conference

Apexus is pleased to announce that the organization’s President, Christopher A. Hatwig, MS, RPh, FASHP, will receive the Winston J. Durant Lecture Award at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Conference, December 8, 2015, in New Orleans. As the honoree, Mr. Hatwig will deliver a luncheon lecture to residency program alumni, current residents, and preceptors who attend the award ceremony.

This prestigious award exemplifies and memorializes Winston Durant who oversaw the growth of the University of Wisconsin (UW) pharmacy department from six pharmacists to more than 100 employees and cultivated revolutionary innovations in pharmacy practice and his never-ending mission to empower the profession of pharmacy. The Winston J. Durant Lecture Award is given annually to a past UW Hospital pharmacy resident for his or her:

  • Significant contributions to pharmacy resident training and/or the mentoring of future leaders

  • Advancement of pharmacy practice and health care systems

  • Demonstration of leadership within the profession

As President of Apexus, Mr. Hatwig is one of the nation’s leading experts on the 340B Drug Pricing Program, which provides deep price discounts for outpatient drugs purchased by clinics and hospitals that serve a significant number of low-income patients. Apexus serves as the 340B Prime Vendor under a contract issued by the U.S. Health Resources and Services Administration (HRSA). In that role, Apexus negotiates significant discounts in drug prices for health care entities that qualify for the 340B Program; it has saved participants more than $1 billion since taking on the role as Prime Vendor. These entities include more than 25,000 HRSA grantees and disproportionate-share hospitals serving the nation’s low-income and uninsured populations.

Mr. Hatwig works closely with HRSA’s Office of Pharmacy Affairs to improve the integrity and value of the 340B Drug Pricing Program through a series of education programs and resources. Since 2011, Mr. Hatwig has led Apexus in establishing the Apexus Answers® national call center and 340B University®, which help various stakeholders better understand the requirements of the 340B program and get answers to their questions. Mr. Hatwig is frequently consulted about maximizing the benefits of the 340B Drug Pricing Program and routinely makes national and regional presentations related to the 340B Program, innovative ambulatory pharmacy services, and drug cost-containment strategies. He recently created a program designed for postgraduate year-two pharmacy residents to do a monthly rotation at Apexus to learn about the 340B Program.

Mr. Hatwig received his bachelor’s degree in pharmacy from the University of Arkansas. He completed residencies in hospital pharmacy and hospital pharmacy administration at the University of Wisconsin, culminating in a master’s degree in hospital pharmacy. Before joining Apexus, he was the director of ambulatory pharmacy services and value analysis programs at Parkland Health & Hospital System in Dallas, where he practiced for 13 years, managing one of the nation’s largest and more progressive ambulatory pharmacy programs serving low-income and uninsured patients. He was responsible for managing Parkland’s network of ambulatory pharmacies, which processed more than two million prescriptions annually and operated with a drug expense budget of $65 million.

Mr. Hatwig is a member of the American Society of Health-System Pharmacists (ASHP), the Academy of Managed Care Pharmacy (AMCP), and the American Pharmacists Association (APhA). He is a recognized Fellow of ASHP and in 2009 received ASHP’s Award of Excellence for his contributions to pharmacy practice.